Summary : Pfizer and Ionis Pharmaceuticals announced that the former is abandoning its vupanorsen program…
Tag:
Ankylosing
-
-
PfizerTofacitinib
Pfizer’s XELJANZ® (Tofacitinib) Receives Marketing Authorization in the European Union for the Treatment of Active Ankylosing Spondylitis
by adminAbstract: The European Commission has approved Pfizer`s first-of-its-kind oral Janus kinase (JAK) inhibitor XELJANZ® (Tofacitinib)…